Teladoc stock slides despite business growth, Medtronic CEO talks innovation

You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday.

Teladoc’s stock slides despite business growth

Teladoc Health on Tuesday reported solid third quarter earnings showing $660 million in revenue for 8% year-over-year growth and improvement across business lines including BetterHelp and its closely watched chronic care segment.

Get unlimited access to award-winning journalism and exclusive events.

Liquidia sues FDA over exclusivity decision to delay Yutrepia’s full approval

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 23, 2024

Peter Orszag wants the FTC and DOJ to stop challenging health care mergers

Peter Orszag was instrumental in crafting the Affordable Care Act. Now, he wants federal antitrust authorities to ease up on their sharp scrutiny of health

August 19, 2024

Say goodbye to the Covid-19 vaccination card. The CDC has stopped printing them

It’s the end of an era for a once-critical pandemic document: The ubiquitous white Covid-19 vaccination cards are being phased out. Now that Covid-19 vaccines

October 5, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.